Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed February 1, 2023
ChromaDex Shares Promising Findings from a Clinical Study Showcasing Combined Metabolic Activators (CMAs), Featuring Nicotinamide Riboside (NR), Improved Cognitive Functions in Alzheimer’s Disease (AD) Patients January 31, 2023